Welcome to our dedicated page for Xos SEC filings (Ticker: XOSWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Xos's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Xos's regulatory disclosures and financial reporting.
RAPP EDWARD J reported acquisition or exercise transactions in this Form 4 filing.
Xos, Inc. director Edward J. Rapp received equity compensation in the form of restricted stock units. He was granted 60,584 RSUs that vest on the earlier of the first anniversary of the grant date or the day before the 2027 annual meeting, subject to continued service, and 2,670 RSUs issued in lieu of his second-quarter 2026 cash retainer as a non-employee director and Audit Committee Chair, which vested immediately on grant. He also reports 21,172 shares of common stock held indirectly through a trust for which he serves as trustee.
Smith John F. reported acquisition or exercise transactions in this Form 4 filing.
Xos, Inc. director Smith John F. received a grant of 60,584 Restricted Stock Units, each representing one share of common stock upon settlement. These RSUs vest on the earlier of the first anniversary of the grant date or the day before the 2027 Annual Meeting, subject to the reporting person's continuous service, and bring direct holdings to 113,562 shares, including 60,584 unvested RSUs.
Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 2,000 shares of Common Stock on June 30, 2026 at $2.89 per share. After this transaction, he directly holds 82,058 shares.
The filing also shows an additional 4,133 shares of Common Stock held indirectly through Bernstein Investment Partners LLC, of which he is the Managing Member, according to the footnote. Within this filing, the sale represents a small fraction of his reported shareholdings.
Xos, Inc. reported the results of its 2026 annual stockholder meeting, where 6,338,211 shares were represented, or 52.57% of the 12,056,211 shares outstanding as of April 24, 2026. Stockholders elected three Class II directors to serve until the 2029 annual meeting and ratified Grant Thornton LLP as independent auditors for 2026.
They approved an amendment to the 2021 Equity Incentive Plan to increase the share reserve by 3,740,000 shares and supported 2025 executive compensation on a non-binding advisory basis. Stockholders also advised holding future say-on-pay votes every three years.
In addition, stockholders approved the potential issuance of 20% or more of the company’s common stock, possibly below the Nasdaq Minimum Price, to holders of certain Convertible Promissory Notes, and approved any related change of control that may be deemed to occur.
Xos, Inc. is offering shares of its common stock having an aggregate offering price of up to $8,779,902 through an at-the-market program with Roth Capital Partners acting as sales agent, pursuant to a Sales Agreement dated June 22, 2026.
The Sales Agreement permits sales from time to time; Roth Capital Partners will receive 3.0% of gross proceeds as compensation. Proceeds are intended for working capital, debt servicing and general corporate purposes and sales are subject to General Instruction I.B.6 to Form S-3 limiting primary offerings to one-third of public float while below $75,000,000. Shares outstanding were 13,718,819 as of June 17, 2026; an illustrative scenario assumes issuance of 2,593,767 shares at $3.385 per share for the full permitted amount.
Emerald Green Trust, together with co-trustees Sarah Bardo and Shane Semler, filed an amended Schedule 13D reporting beneficial ownership of Xos, Inc. common stock. Emerald Green beneficially owns 1,161,229 shares, representing 8.5% of the common stock, based on 13,658,411 shares outstanding as of June 4, 2026.
Bardo is reported as beneficially owning 1,161,232 shares, including trust holdings and 3 shares held by her spouse, while Semler is reported as beneficially owning 1,167,232 shares, including 6,003 shares held directly. The filing also notes that Emerald Green sold 119,960 shares on June 3, 2026 at a weighted average price of approximately $6.0562 per share and 280,040 shares on June 4, 2026 at a weighted average price of approximately $5.2439 per share.
Xos, Inc. Chief Executive Officer Dakota Semler reported a routine tax-related share disposition. On this Form 4, 14,538 shares of common stock were withheld by the company at $3.66 per share to cover tax obligations tied to previously granted Restricted Stock Unit (RSU) awards.
These shares were not sold in the open market, but retained by the issuer to satisfy withholding requirements when RSUs vested. After this transaction, Semler directly holds 832,523 shares of common stock, and the position also includes 471,975 unvested RSUs that may settle into additional shares over time.